Study of PrEP choices in women and transgender people
Part of Infections clinical trials.
This study asks people who may use PrEP—an HIV prevention medicine—about their decision to start, not start, or stop PrEP. It aims to understand needs and barriers so PrEP can work better for cisgender women and transgender people who are considering it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a cisgender woman or a transgender person
- You have a reason to consider PrEP (HIV prevention medicine)
- You have decided to start PrEP, not start PrEP, or stop PrEP
- You can understand the study and give informed consent
- You do not currently live with HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a decision-making tool to help transgender women choose the right PrEP (HIV prevention pill) for them. It is looking for transgender women in Denver who are HIV-negative and interested in learning more about PrEP, as well as healthcare providers who help transgender women decide about PrEP.
This study tests ways to help Black cisgender women take PrEP, a daily pill that prevents HIV infection. It focuses on making PrEP work for you.
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.
This study tests a program that helps Black women start PrEP (a daily pill to prevent HIV). It focuses on understanding and addressing past trauma to make it easier to take PrEP, and is designed for women who have not used PrEP before.
This study tests a counseling program to help women decide whether to use PrEP (a daily pill that prevents HIV). It aims to make PrEP choices easier and more informed in sexual and reproductive health clinics.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.